Knocking down TNFAIP1 alleviates inflammation and oxidative stress in pediatric pneumonia through PI3K/Akt/Nrf2 pathway
Main Article Content
Keywords
inflammatory, oxidative stress, pediatric pneumonia, PI3K/Akt/Nrf2, TNFAIP1
Abstract
Background: Pneumonia is an acute respiratory infection with increasing global incidences. Children are more susceptible to pneumonia than adults, and its incidences grow extremely high during peak seasons. Thus, it is necessary to investigate the pathogenesis and molecular mechanism of childhood pneumonia.
Methods: This study examined the role of tumor necrosis factor alpha-inducible protein 1 (TNFAIP1) in lipopolysaccharide (LPS)-induced pneumonia mice. After LPS exposure, lung function, TNFAIP1 activation, infarction volume, oxidative stress, lung tissue apoptosis ratio, and inflammatory response were assessed by immunohistochemistry staining, hematoxylin and eosin staning, Western blot analysis, terminal deoxynucleotidyl transferase dUTP nick end labelling assay, and enzyme-linked-immunosorbent serologic assay, respectively. The mechanism of TNFAIP1 regulating phosphoinositide 3-kinases (PI3K)–protein kinase B (Akt)–nuclear factor erythroid 2-related factor 2 (Nrf2) pathway was analyzed by Western blot analysis.
Results: TNFAIP1 expression was enhanced in the LPS-induced pneumonia mice but was negatively correlated with the LPS-induced lung injury. Silencing TNFAIP1 alleviated inflammatory response, production of reactive oxygen species (ROS), and cellular apoptosis in LPS-induced pneumonia. Moreover, PI3K/Akt/Nrf2 signaling pathways were predominantly involved in the TNFAIP1-mediated lung injury, which also played a role in the process of LPS-induced pneumonia.
Conclusion: This study suggested that TNFAIP1 acted as a negative regulator of acute pneumonia by attenuating inflammatory response, production of ROS, and cellular apoptosis via PI3K/Akt/Nrf2 pathway. The findings suggested that TNFAIP1 is a potential candidate for pneumonia therapy.
References
2. Kumar V. Pulmonary innate immune response determines the outcome of inflammation during pneumonia and sepsis--associated acute lung injury. Front Immunol. 2020;11:1722. 10.3389/fimmu.2020.01722
3. Cillóniz C, Torres A, Niederman M, van der Eerden M, Chalmers J, Welte T, et al. Community-acquired pneumonia related to intracellular pathogens. Intensive Care Med. 2016; 42(9):1374–86. 10.1007/s00134-016-4394-4
4. Zhang P, Cao L, Zhou R, Yang X, Wu M. The lncRNA Neat1 promotes activation of inflammasomes in macrophages. Nature Commun. 2019;10(1):1–17. 10.1038/s41467-019-09482-6
5. Kalil AC, Thomas PG. Influenza virus-related critical illness: Pathophysiology and epidemiology. Crit Care. 2019;23(1):1–7. 10.1186/s13054-019-2539-x
6. Granger DN, Kvietys PR. Reperfusion injury and reactive oxygen species: The evolution of a concept. Redox Biol. 2015;6:524–51. 10.1016/j.redox.2015.08.020
7. Ornatowski W, Lu Q, Yegambaram M, Garcia AE, Zemskov EA, Maltepe E, et al. Complex interplay between autophagy and oxidative stress in the development of pulmonary disease. Redox Biol. 2020;36:101679. 10.1016/j.redox.2020.101679
8. Cemek M, Çaksen H, Bayiroğlu F, Cemek F, Dede S. Oxidative stress and enzymic–nonenzymic antioxidant responses in-children with acute pneumonia. Cell Biochem Funct Cell Biochem Modulation Active Agents Dis. 2006;24(3):269–73. 10.1002/cbf.1220
9. Chen Y, Yang Z, Meng M, Zhao Y, Dong N, Yan H, et al. Cullin mediates degradation of RhoA through evolutionarily conserved BTB adaptors to control actin cytoskeleton structure and cell movement. Mol Cell. 2009;35(6):841–55. 10.1016/j.molcel.2009.09.004
10. Zhu Y, Yao Z, Wu Z, Mei Y, Wu M. Role of tumor necrosis factor alpha-induced protein 1 in paclitaxel resistance. Oncogene. 2014;33(25):3246–55. 10.1038/onc.2013.299
11. Xiao Y, Huang S, Qiu F, Ding X, Sun Y, Wei C, et al. Tumor necrosis factor α-induced protein 1 as a novel tumor suppressor through selective downregulation of CSNK2B blocks nuclear factor-κB activation in hepatocellular carcinoma. EBio Med. 2020;51:102603. 10.1016/j.ebiom.2019.102603
12. Qiu F, Zhou Y, Deng Y, Yi J, Gong M, Liu N, et al. Knockdown of TNFAIP1 prevents di-(2-ethylhexyl) phthalate-induced neurotoxicity by activating CREB pathway. Chemosphere. 2020;241:125114. 10.1016/j.chemosphere.2019.125114
13. Wen L, Yang Q-H, Ma X-L, Li T, Xiao S, Sun C-F. Inhibition of TNFAIP1 ameliorates the oxidative stress and inflammatory injury in myocardial ischemia/reperfusion injury through modulation of Akt/GSK-3β/Nrf2 pathway. Int Immunopharmacol. 2021;99:107993. 10.1016/j.intimp.2021.107993
14. Sadrkhanloo M, Entezari M, Orouei S, Zabolian A, Mirzaie A, Maghsoudloo A, et al. Targeting Nrf2 in ischemia--reperfusion alleviation: From signaling networks to therapeutic targeting. Life Sci. 2022:120561. 10.1016/j.lfs.2022.120561
15. Cardinale F, Cappiello AR, Mastrototaro MF, Pignatelli M, Esposito S. Community-acquired pneumonia in children. Early Hum Dev. 2013;89:S49–52. 10.1016/j.earlhumdev.2013.07.023
16. Nova Z, Skovierova H, Calkovska A. Alveolar-capillary membrane-related pulmonary cells as a target in endotoxin--induced acute lung injury. Int J Mol Sci. 2019;20(4):831. 10.3390/ijms20040831
17. Dhanireddy S, Altemeier WA, Matute-Bello G, O'Mahony DS, Glenny RW, Martin TR, et al. Mechanical ventilation induces inflammation, lung injury, and extra-pulmonary organ dysfunction in experimental pneumonia. Lab Invest. 2006;86(8):790–9. 10.1038/labinvest.3700440
18. Zhao Y, Li S, Xia N, Shi Y, Zhao CM. Effects of XIST/miR-137 axis on neuropathic pain by targeting TNFAIP1 in a rat model. J Cell Physiol. 2018;233(5):4307–16. 10.1002/jcp.26254
19. Xiao Y, Li Y, Zhang H, Yang L, Jiang Y, Wei C, et al. TNFAIP1 is upregulated in APP/PS1 mice and promotes apoptosis in SH-SY5Y cells by binding to RhoB. J Mol Neurosci. 2021;71(6):1221–33. 10.1007/s12031-020-01748-9
20. Fatmi A, Chabni N, Cernada M, Vento M, González-López M, Aribi M, et al. Clinical and immunological aspects of microRNAs in neonatal sepsis. Biomed Pharmacother. 2022;145:112444. 10.1016/j.biopha.2021.112444
21. Chi G, Wei M, Xie X, Soromou L, Liu F, Zhao S. Suppression of MAPK and NF-κB pathways by limonene contributes to attenuation of lipopolysaccharide-induced inflammatory responses in acute lung injury. Inflammation. 2013;36(2):501–11. 10.1007/s10753-012-9571-1
22. Zhong WJ, Yang HH, Guan XX, Xiong JB, Sun CC, Zhang CY, et al. Inhibition of glycolysis alleviates lipopolysaccharide-induced acute lung injury in a mouse model. J Cell Physiol. 2019;234(4):4641–54. 10.1002/jcp.27261
23. Palipoch S, Koomhin P. Oxidative stress-associated pathology: A review. Sains Malaysiana. 2015;44(10):1441–51. 10.17576/jsm-2015-4410-09
24. Beker MC, Caglayan B, Caglayan AB, Kelestemur T, Yalcin E, Caglayan A, et al. Interaction of melatonin and Bmal1 in the regulation of PI3K/AKT pathway components and cellular survival. Sci Rep. 2019;9(1):1–17. 10.1038/s41598-019-55663-0
25. Niture SK, Kaspar JW, Shen J, Jaiswal AK. Nrf2 signaling and cell survival. Toxicol Appl Pharmacol. 2010;244(1):37–42. 10.1016/j.taap.2009.06.009
26. Galiè M, Covi V, Tabaracci G, Malatesta M. The role of Nrf2 in the antioxidant cellular response to medical ozone exposure. Int J Mol Sci. 2019;20(16):4009. 10.3390/ijms20164009
27. Meng J, Chen Y, Wang J, Qiu J, Chang C, Bi F, et al. EGCG protects vascular endothelial cells from oxidative stress--induced damage by targeting the autophagy-dependent PI3K-AKT-mTOR pathway. Ann Transl Med. 2020;8(5):200. 10.21037/atm.2020.01.92
